As a neurosurgical oncologist at Barrow Neurological Institute, Dr. Kris Smith is determined to improve the outcome for brain tumor patients. But when his father was diagnosed with glioblastoma, the battle against brain cancer became all the more personal. Hear Dr. Smith discuss targeted glioblastoma therapies and why it is important to him.
To read Dr. Smith's full #ItsPersonal story, visit: [ Ссылка ]
-------------------------------------------------------------------------------------------------------------------------------
The Ivy Brain Tumor Center ([ Ссылка ]) at Barrow Neurological Institute in Phoenix, AZ, is a non-profit translational research program that employs a bold, early-phase clinical trials strategy to identify new treatments for aggressive brain tumors, including glioblastoma. The Ivy Center’s Phase 0 clinical trials program is the largest of its kind in the world. It enables personalized care in a fraction of the time and cost associated with traditional drug development. In addition, unlike conventional clinical trials focusing on single drugs, its accelerated trials program tests therapeutic combinations matched to individual patients.
How Ivy Phase 0 Clinical Trials Work: [ Ссылка ]
Benefits of Ivy Phase 0: [ Ссылка ]
Curious if you or a loved one may be eligible for one of our clinical trials? Submit a free trial screening request today at
[ Ссылка ] or call 602-406-8605.
Active Clinical Trials: [ Ссылка ]
Clinical Trial Eligibility: [ Ссылка ]
Learn more about Ivy Brain Tumor Center: [ Ссылка ]
Learn more about Barrow Neurological Institute: [ Ссылка ]
Donate to Brain Tumor Research: [ Ссылка ]
